Bioengineering Research Grants (R01 Clinical Trial Optional)
This grant supports small multidisciplinary teams using bioengineering approaches to develop and advance innovative tools or methods for solving biomedical research or clinical problems.
Funder: National Institutes of Health
Due Dates: July 5, 2029 (Full application deadline)
Funding Amounts: Up to $500,000 per award; duration and number of awards vary
Summary: Supports multidisciplinary bioengineering research to solve biomedical problems and accelerate translational adoption of innovative tools, methods, or techniques.
Description
This opportunity supports research projects that bring together the life and physical sciences to address biomedical problems using multidisciplinary bioengineering approaches. The program aims to integrate, optimize, validate, translate, or otherwise accelerate the adoption of promising tools, methods, and techniques for specific research or clinical challenges in basic, translational, or clinical science and practice.
Projects may be design-directed, developmental, discovery-driven, or hypothesis-driven, and are suitable for small teams applying integrative strategies to advance understanding or solve problems in biological, clinical, or translational science. The program will support clinical trials that test functionality or validate performance within the intended setting, but does not support conventional clinical trials lacking translational motivation or commercial production. Phase III clinical trials are specifically excluded.
